Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoadjuvant Radiotherapy”

696 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 696 results

Testing effectiveness (Phase 2)Looking for participantsNCT05851924
What this trial is testing

NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Memorial Sloan Kettering Cancer Center 60
Not applicableStudy completedNCT05292027
What this trial is testing

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Sichuan Cancer Hospital and Research Institute 84
Not applicableUnknownNCT06313073
What this trial is testing

Neoadjuvant Radiotherapy for Breast Cancer

Who this might be right for
Neoadjuvant RadiotherapyBreast Cancer
Changhai Hospital 60
Early research (Phase 1)UnknownNCT05185531
What this trial is testing

Neoadjuvant Tislelizumab With SBRT in Patients With Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Shandong Cancer Hospital and Institute 20
Testing effectiveness (Phase 2)Study completedNCT04996797
What this trial is testing

Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Who this might be right for
Ulcerative Colitis
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 178
Not applicableUnknownNCT04489368
What this trial is testing

Response Prediction to Neoadjuvant Chemoradiation in Esophageal Cancer Using Artificial Intelligence & Machine Learning

Who this might be right for
Esophageal Neoplasm
Dr Kundan Singh Chufal 150
Testing effectiveness (Phase 2)Looking for participantsNCT07198165
What this trial is testing

SCRT Followed by CAPOX + Bev ± PD-1 Inhibitor for TNT in LARC

Who this might be right for
Rectal CancerRectal AdenocarcinomaRectal Cancer, Radiotherapy+6 more
Ruijin Hospital 104
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092
What this trial is testing

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Who this might be right for
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Montefiore Medical Center 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT04938609
What this trial is testing

Neoadjuvant Immunoradiotherapy in Head & Neck Cancer (NIRT 2-HNC)

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
Providence Health & Services 28
Testing effectiveness (Phase 2)Study completedNCT00408564
What this trial is testing

Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
Medical University of South Carolina 39
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07612098
What this trial is testing

Preoperative Radiotherapy and Anlotinib With or Without Penpulimab for Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma (STS)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 274
Not applicableActive Not RecruitingNCT05524012
What this trial is testing

Longitudinal Multimodal Response Assessment During Neoadjuvant Treatment of Rectal Cancer

Who this might be right for
Locally Advanced Rectal CarcinomaNeoadjuvant TreatmentRadiotherapy+1 more
Jena University Hospital 40
Testing effectiveness (Phase 2)UnknownNCT00689702
What this trial is testing

Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Institute of Oncology Ljubljana 43
Not applicableStudy completedNCT04943419
What this trial is testing

Myeloid-derived Suppressor Cells in Colorectal Cancer

Who this might be right for
Colorectal CancerSuppressionComplication,Postoperative+1 more
Jagiellonian University 90
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05969847
What this trial is testing

Organ Preservation Following Enverolimab-based Total Neoadjuvant Therapy for Locally Advanced Very Low Rectal Cancer

Who this might be right for
Rectal Cancer
池畔 72
Testing effectiveness (Phase 2)Study completedNCT02864849
What this trial is testing

Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer

Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 81
Testing effectiveness (Phase 2)Active Not RecruitingNCT02971748
What this trial is testing

Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy

Who this might be right for
Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8Breast Inflammatory Carcinoma+2 more
M.D. Anderson Cancer Center 36
Testing effectiveness (Phase 2)UnknownNCT06391008
What this trial is testing

Immunosensitized Radiotherapy Combined With Evoximab (AK112) and Chemotherapy Neoadjuvant Therapy for Stage II-III Non-small Cell Lung Cancer

Who this might be right for
Stereotactic Radiotherapy; Evoximab (AK112); New Adjuvant Therapy for Non-small Cell Lung Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 44
Not applicableStudy completedNCT02208024
What this trial is testing

Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body

Who this might be right for
Pancreatic Cancer
University of Cincinnati 18
Not applicableUnknownNCT04564482
What this trial is testing

PD-L1 PET Imaging During Neoadjuvant (Chemo)Radiotherapy in Esophageal and Rectal Cancer

Who this might be right for
Rectal Cancer StageOesophageal Cancer
Johannes Laengle, MD, PhD 20
Next Page